Patients with acute myocardial infarction (AMI) who are at risk of developing cardiogenic shock (CS) in the hospital after percutaneous coronary intervention (PCI) do not see a reduction in N-terminal pro B-type natriuretic peptide (NT-proBNP) levels from early dobutamine infusion, though systolic blood pressure (BP) does decrease.